ArticleLife (Basel, Switzerland)2026
Feasibility and Clinical Outcomes of a 6-Month Home-Based Telerehabilitation Program in Patients with Peripheral Arterial Disease: A Prospective Single-Arm Study.
Article in Life (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
(1) Background: Peripheral arterial disease (PAD) is associated with substantial cardiovascular morbidity and functional impairment. This study evaluated the feasibility and adherence of a 6-month home-based telerehabilitation (TR) program and longitudinal changes in functional capacity, health-related quality of life (HRQoL), and selected cardiometabolic parameters. (2) Methods: This prospective, single-arm study enrolled 42 patients with PAD. Daily ambulation was monitored using a Xiaomi Smart Band 8, and participants received weekly telephone counseling. Assessments were performed at baseline, 3 months, and 6 months. (3) Results: Median daily step count increased from 5868 to 6905 steps/day (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.